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Introduction: The recent global expansion of routine adolescent vaccination programmes has the poten-
tial to protect young people against infectious diseases and improve their health. Although the legal
framework in many countries permits young people to consent for vaccinations if competent, lack of
written parental consent can still prevent uptake. We aimed to review systematically the associated bar-
riers and enablers to implementation of adolescent self-consent procedures.
Methods: A comprehensive search strategy of ten databases from inception to June 2018 was undertaken
to identify relevant qualitative and quantitative studies. Titles, abstracts and full texts were assessed for
eligibility, and the methodological quality of eligible primary studies evaluated. Thematic synthesis
methods were used to interpret and combine qualitative data, and to identify overarching themes as well
as similarities and differences within themes. Quantitative data were summarised and, because the data
were sufficiently similar in focus, were integrated within the qualitative framework.
Results: Twenty-five publications related to 23 studies were included. Three themes were identified
which related to the policy framework, protection, and self-determination. Despite supportive national
policy frameworks, implementation of adolescent self-consent procedures can be prevented by local poli-
cies, professionals’ misunderstandings of the legal framework and the context in which the vaccination
programme is delivered. Motivation to protect young people’s health increased acceptability of adoles-
cent self-consent, but implementation might be prevented to protect the reputation of professionals or
relationships with parents. Further, maintaining the role of parents as decision-makers for their child’s
healthcare was frequently prioritised over enabling young people’s autonomy to consent.
Conclusions: Barriers to the implementation of adolescent self-consent procedures have implications for
young people’s health and uptake of vaccination programmes. There is a need to clarify the policy frame-
work and challenge the primacy of parental consent.
Systematic review registration: PROSPERO CRD42017084509.
 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
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The number of routine vaccinations recommended during ado-
lescence is increasing, and includes vaccines that protect against
acquisition of tetanus, diphtheria, meningococcal disease and
human papillomavirus (HPV) [1,2]. The expansion of adolescent
vaccination programmes may improve young people’s health by
protecting them from potentially life-threatening infectious dis-
eases. In some countries, high uptake of adolescent vaccination
programmes has been achieved [3–5]. However, national data
often conceals within country inequalities in uptake and access.
For example, in England the overall uptake of Td/IPV booster vac-
cination programme in 2016/17 was 82% (range: 44–100%). Fur-
ther, in 14 of the 152 local authorities uptake was less than 70%
[4]. Further, evidence from a systematic review and meta-
analysis showed that young women from minority ethnic popula-
tions and without healthcare insurance were less likely to initiate
the HPV vaccination series [6]. Targeting specific populations iden-
tified with lower uptake with focused interventions, such as intro-
duction of adolescent self-consent procedures, could help ensure
higher and more equitable uptake across all population groups.
The introduction of new adolescent vaccination programmes is
relevant to the debate about young people’s capacity to provide
consent to receive medical treatment. The United Nations Conven-
tion on the Rights of the Child recognises the right for all children
and young people to participate in decision-making processes
which involve them [7]. However, the World Health Organisation
has acknowledged difficulties over consent for vaccination of ado-
lescents because of their age, and describes current practice
through which countries are encouraged to adopt procedures that
ensure parents have been informed and have agreed to the vacci-
nation [8].
In most countries, the legal framework for consent requires par-
ental or guardian permission for young people aged below 18 years
[8]. However, the age of consent for medical interventions, such as
vaccination programmes, is lower in some countries. In the UK,
Canada and Sweden, young women are legally able to override par-
ental decisions if they are considered mature enough to make, and
understand the consequences of, the decision to vaccinate. InAustralia and the USA, there are geographic variations of the age
(12–17 years) that a young person can consent to be vaccinated.
Despite young people being supported by the law to provide con-
sent themselves, written parental consent is usually sought.
It is currently unknown whether the introduction of adolescent
self-consent procedures can increase uptake of adolescent vaccina-
tion programmes. This paper reports the findings of a mixed-
methods systematic review aiming to identify, appraise and syn-
thesise the available qualitative and quantitative literature relating
to self-consent procedures for adolescent vaccination programmes.
The original primary research question was to describe the effec-
tiveness of self-consent interventions at increasing uptake of ado-
lescent vaccination programmes. However, no such intervention
studies were retrieved. As a result, the findings presented here
are relevant to the secondary research objective: to report the bar-
riers and enablers of implementation of self-consent procedures
for adolescent vaccination programmes.2. Material and methods
The full details of the methodology for this study are available
in a published protocol [9]. This systematic review was registered
with the International Prospective Register of Systematic Reviews
(PROSPERO) (Registration number: CRD42017084509).2.1. Search strategy and study selection
A search strategy was developed which combined Medical Sub-
ject Headings (MeSH) for young people (e.g. child, adolescent),
with terms for vaccination programmes (e.g. immunization) and
self-consent (e.g. decision-making, informed consent) (Fig. 1).
Studies for inclusion were identified through a broad search of
ten databases proposed in the protocol [9] from inception to Jan-
uary 2018. The search was updated in June 2018.
Two reviewers (HF & SH) independently assessed the titles and
abstracts, and full-text publications of all potentially relevant arti-
cles were retrieved and scrutinised for relevance. Disagreements
were resolved by discussion. Reference lists and bibliographies
1. child/ 
2. adolescent/
3. ( "Young people#" OR "young person#" OR "young offender#" OR adolescent# OR adolescence 
OR youth# OR minor# OR teen OR teens OR teenage OR teenaged OR teenager# OR juvenile# 
OR pupil# OR boy# OR girl# OR underage# OR daughter# or son# (school AND dropout#) OR 
(school AND "drop out#") OR "school aged").mp.
4. active immunization/
5. immunization/
6. immunization programs/
7. mass immunization/
8. revaccination/
9. vaccination/ 
10. diphtheria vaccine/
11. diphtheria tetanus vaccine/
12. diphtheria pertussis tetanus Haemophilus influenzae type b vaccine/
13. hepatitis B vaccine/
14. meningococcus vaccine/
15. rubella vaccine/
16. wart virus vaccine/
17. Papillomavirus Vaccines/ 
18. (cervical cancer or diptheria or diphtheria or diphteria or DtaP or DTP or Hep B or hepatitis or 
HPV or measles or MenC or MenACWY or meningitis or Meningococcal or Neisseria meningitidis 
or papillomavirus or pertus* or rubella or rubeola or td?ipv or tetanus or wart virus or whoop*).tw.
19. (policy OR program*)
20. (immuniz* OR immunis* OR immunother* OR inoculat* OR innoculat* OR prophyla* OR 
revaccinat* OR vaccin*).mp.
21. Decision making/
22. Informed consent/
23. Parental consent/
24. Treatment refusal/
25. (assent* OR competen* OR decision-making OR decision making OR Gillick OR Fraser OR 
inform* consent OR mental capacity OR minor consent OR parent* consent OR permission* OR 
presume* consent OR treatment refusal OR self consent OR self-consent OR opt-out OR opt-
in).mp.
26. 1 or 2 or 3
27. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
28. 18 and 20
29. 19 and 20
30. 27 or 28 or 29 
31. 21 or 22 or 23 or 24 or 25
32. 26 and 30 or 31
Fig. 1. Embase search strategy.
H. Fisher et al. / Vaccine 37 (2019) 417–429 419from eligible studies and systematic reviews were hand-searched.
The reference management software EndNote X8 was used and
study selection process documented using a PRISMA flow diagram
[10].
2.2. Inclusion and exclusion criteria
Qualitative and quantitative studies reporting the views and
experiences of key stakeholders in relation to implementation of
self-consent procedures in vaccination programmes for young peo-
ple aged between ten and 18 years were included [11]. Eligible
stakeholders included young people, parents or primary caregivers,
healthcare professionals, policy makers, community leaders and
teachers. Studies related to consent procedures solely targeting
parents of adolescents, or early childhood and adult vaccination
programmes were not eligible. Studies which used interviews,
focus groups, observations, surveys, and questionnaires withclosed or open-ended questions allowing free-text responses were
included. Conference abstracts, reviews, editorials, opinion pieces,
dissertations, letters and books were included if they presented
original data. No language or country of origin restriction was
imposed.2.3. Data extraction
Two reviewers (HF & SH) independently extracted data from
selected studies using structured and standardised data extraction
forms adapted from previous systematic reviews [6,12]. Multiple
publications related to the same study were reported together.
Relevant domains such as study characteristics (e.g. authors, pub-
lication year, country), participant characteristics (e.g. participant
age, sample size) and study results were retrieved. Any discrepan-
cies were resolved through discussion.
420 H. Fisher et al. / Vaccine 37 (2019) 417–4292.4. Risk of bias
Assessment of risk of bias was undertaken independently by
two reviewers (HF & SH) to illustrate potential sources of bias
and recorded with an overall assessment of ‘low’, ‘moderate’, and
‘high’ in an excel spreadsheet. As the majority of eligible studies
were observational, studies were not excluded on the basis of
‘high’ risk of bias if considered to contribute relevant information.
We used the NIH Quality Assessment Tool for Observational Cohort
and Cross-Sectional Studies [13] and the Critical Appraisal Skills
Programme criteria adapted for qualitative studies [14]. For studies
reporting both qualitative and quantitative data related to self-
consent, the quality assessment tool related to the main data col-
lection method used.2.5. Data synthesis: Qualitative and quantitative studies
No single unifying framework exists for synthesising quantita-
tive and qualitative evidence in systematic reviews [15]. The
methodology for thematic synthesis reported by Thomas and Har-
den [16], which is suited to studies with a priori aims and objec-
tives, was initially used to synthesise the qualitative data. The
overall purpose of the qualitative synthesis was to ‘pool’ the results
from individual primary studies by initially separating the findings,
coding and interpreting the text, and then combining them
through the identification of key themes across the studies as well
as similarities and differences within those themes [17]. Thematic
synthesis was carried out by one experienced reviewer (HF) who
discussed interpretations of the data with a second reviewer (SA).5,692 records identified through 
database searching
65 full-text studies assessed 
for eligibility 
4,140 records screened after duplicates 
removed
3 additional re
other
14 publications reporting 
qualitative components 
related to 13 studies 
13 publications rep
quantitative compo
related to 12 stu
25 publications related to 23
studies identified
Fig. 2. Flow diagram of studFamiliarisation with the dataset began with reading the full
papers. Pertinent sections of the text, including participant quotes
and text written by the primary study authors, related to self-
consent reported in the results section of each primary study rep-
resented the basic units for analysis and were uploaded to QSR
NVivo11 software. An initial coding framework was developed,
allowing for additional codes to emerge from the data. Refinements
were made to the coding framework as data analysis progressed.
During this process, overarching themes were identified, and dif-
ferences or similarities explored within these emerging themes.
We originally planned to synthesise quantitative data through a
meta-analysis, however this was not possible due to heterogeneity
of outcomes and a lack of suitable data to calculate standardised
effect sizes [18]. Initially, narrative descriptions of the results were
created by extracting relevant key concepts and summarising find-
ings [15]. Following consensus of the qualitative coding frame-
work, the descriptions of individual quantitative studies were re-
examined. As the focus of the qualitative and quantitative data
were considered sufficiently similar, the quantitative data was sub-
sequently integrated into a single synthesis based on the qualita-
tive framework [19].
3. Results
Of 5,820 records identified, 4,140 abstracts were reviewed, and
65 full-text articles were assessed for eligibility. Full-text studies
were excluded for: not being related to adolescent self-consent
(n = 16); not being related to population group of interest (8),
and; not presenting primary data (16). A total of 25 publications
related to 23 studies met the inclusion criteria (Fig. 2).40 full-text studies excluded for being:
- not self-consent (n=16)
- not in relation to young people / not 
population of interest (n=8)
- no primary data presented (n= 16)
cords identified by 
 sources
orting 
nents 
dies
- Title/abstract excluded (n=4,074)
- Library unable to locate full text (n=1)
125 records identified during 
update of searches 
y selection procedure.
H. Fisher et al. / Vaccine 37 (2019) 417–429 421The majority of studies were undertaken in UK (n = 10, 43.5%)
and the USA (9, 39.1%), with one additional study each from
Canada, Sweden, Australia and Tanzania. Most of the studies either
used qualitative methodologies (11, 47.8%) or comprised a ques-
tionnaire (8, 34.8%). Additional single studies reported mixed
methodologies, an educational intervention, a semi-qualitative
questionnaire, and a needs assessment (methodology unclear).
Twelve (52.2%) of the studies were in relation to HPV vaccination
programmes, five (21.7%) referenced to multiple adolescent vacci-
nation programmes, and the remaining six (26.1%) were non-
specified adolescent vaccination programmes (Table 1).
3.1. Qualitative studies summary
Fourteen publications [20–33] relating to 13 studies reported
relevant data using qualitative research methods within their
study design. The most frequent data collection method was inter-
views [20–24], in addition to focus groups and interviews [28–30],
interviews combined with observations [26,27], focus groups
[25,33], semi-qualitative questionnaires [32], and citizen juries
[31]. Study participants were diverse. Eleven of the studies com-
prised healthcare professionals [20–30], seven involved young
people [26–28,30,31,33], and five included parents
[27,28,30,32,33] (Table 1).
3.2. Quantitative studies summary
Thirteen publications [27,32,34–44] relating to 12 studies
reported relevant data using quantitative research methods. All
used questionnaires to elicit responses from study participants.
Participants comprised young people in eight of the studies
[27,34,36,39–43], parents of adolescents in four studies
[32,39,41,43], healthcare professionals in two studies [37,38], and
two studies were related to healthcare organisations [35,44]
(Table 1).
3.3. Risk of bias assessment
The majority of the studies reporting mainly qualitative data in
relation to self-consent were considered at ‘low’ [20–22,25,27] or
‘moderate’ [23,24,28–30] risk of bias (Table 2). Three studies were
considered at ‘high’ risk of bias [31–33]. All primary studies explic-
itly defined the aims of the research for which a qualitative
research approach was appropriate. Only two studies presented a
reflection on how the researcher could introduce bias during data
collection or interpretation of the study findings [25,27]. Study
design increased the risk of bias being introduced to the study:
one study classified as being at ‘high’ risk of bias incorporated a
semi-qualitative research design using free text responses from a
questionnaire study [32] and a second used ‘citizen juries’ [31].
For the third study at ‘high’ risk of bias, the data was presented
as a poster with limited information available [33] (Table 2).
Of the studies reporting primarily quantitative data in relation
to self-consent, all studies were classified as being at ‘high’ risk
of bias [27,32,34–44], resulting from the use of descriptive, cross-
sectional questionnaires that elicited subjective information from
participants at a single time-point (Table 3).
3.4. Themes
The data suggest that the implementation of adolescent self-
consent procedures is influenced by three broad themes: the policy
framework, notions of ‘protection’, and self-determination of
young people. These are discussed below from the perspectives
of the different stakeholders involved. Illustrative quotations werechosen because they were articulated concisely and typify
responses relating to the themes.
3.5. Policy framework
Within the policy framework theme, issues related to imple-
mentation of self-consent procedures were grouped into the fol-
lowing sub-themes: national and local policy frameworks,
understanding of legal guidelines, and context.
3.6. National and local policy frameworks
Seven studies undertaken in five countries discussed the
national legal framework for assessing adolescent self-consent
for vaccination. In the UK (England, Scotland and Wales) and Swe-
den, an adolescent who demonstrates themselves to be competent
are legally entitled to provide consent for vaccination without their
parents’ knowledge [20,23,25,27,30]. In the USA, young people are
able to provide consent for healthcare that relates to sexually
transmitted infections and family planning [24] and vaccinations
conferring protection against sexually transmitted infections [35].
Despite the existence of a supportive national policy framework
in the UK, local policy decisions may constrain healthcare profes-
sionals in assessing young women’s competency [20,27]: ‘‘From
the nurse’s point of view, because we use a directive which says it must
be parental written consent, we would not have been able to give it”
(Respondent 24, Wales) [20].
3.7. Understanding of legal guidelines
Some studies indicated lack of clarity regarding legal guidelines
acted as a barrier to adolescent self-consent. Some professionals
were aware of the legal framework for young people to consent
to healthcare decisions, but appeared to disagree that it should
be applied in the context of adolescent vaccination programmes
[20,23,24]: ‘‘I think it would be very unwise to simply say ‘This girl
is Gillick competent, I’m not going to enter into discussion with the
parents and I’m going to vaccinate her now’ ” (Respondent 9, Wales,
[20]). Often healthcare professionals incorrectly referenced
national policy for obtaining young people’s consent
[20,21,25,27]. This included misperceptions of recent legislation
changes in the USA which now allows adolescent self-consent for
HPV vaccination (no further detail provided) [35], and reference
to the UK Fraser guidelines which specifically address provision
of contraceptive advice to young people without the knowledge
of their parents, rather than vaccination [20,21,27]: ‘‘We are using
Fraser guidelines, which started off being on contraception and I know
we can use it in all realms” (School nurse 13, England, [21]). Simi-
larly, parents were not always aware of the legal framework [32].
3.8. Context
Differing levels of acceptability of adolescent self-consent were
evident by country and the setting of programme delivery. In the
USA, data elicited from interviews indicated healthcare profession-
als felt obtaining consent from young people presenting for health-
care appointments unaccompanied was challenging [24,29]: ‘‘A
whole bunch of adolescents will come in for preparticipation sports
physicals. That is how they get their routine healthcare. We have not
been giving immunizations. They do not routinely have parents pre-
sent, and the issue of consent gets complicated” (Key informant,
USA, [24]).
In contrast, British and Swedish school nurses were generally
more supportive towards self-consent for vaccinations provided
it took place in a clinical context [20,23,25]. There was less support
for self-consent to be assessed in the school setting. Barriers to
Table 1
Description of primary studies.
Authors Publi-
cation
year
Aim Study Location -
Geographical
Data
collection
period
Data collection
methods
Sampling strategy Analytical
method
Participants Vaccination
programme
Authors conflicts of
interest
Batista
Ferrer, H,
et al.
[26,27]
2015 To identify the barriers and facilitators
to uptake of the HPV vaccine in an
ethnically diverse group of young
women in the south west of England
Three state-
funded
comprehensive
schools in the
south west of
England, UK
Oct 2012-
Jul 2013
Observations,
semi-
structured
interviews &
cross-sectional
questionnaire
Purposive sample of
schools and young women
based on vaccine uptake,
ethnicity, and Free School
Meal entitlement
Thematic
analysis &
Framework
approach to
data
management
Interviews: 6 key stakeholders &
23 ethnically diverse young
women aged 12–13 years (68%
response rate); questionnaire:
137 young women
HPV Consultancy payment
from GSK for a critical
review of a health
economic model of
meningococcal ACWY
vaccine
Brabin L,
et al. [32]
2007 To explore parents’ views on HPV
vaccination in the context of
adolescent autonomy
Eight schools in
the city of
Manchester, UK
Mar-Apr
2005
Semi-
qualitative,
cross-sectional
questionnaire
A stratified sample of
schools were invited based
on school type and
ethnicity; All parents of
female year 7 pupils at
participating schools
Descriptive
analysis &
summary of
open-ended
questions
317 parents of female students
aged 11–12 years in
participating schools (22%
response rate)
HPV Travel grants and
funding from GSK for
a vaccine clinical trial
Brabin L,
et al. [34]
2009 To assess adolescent acceptance of
HPV vaccination and the role of girls
in the decision-making process
Two Primary
Care Trusts,
Manchester, UK
Not
reported
Cross-sectional
questionnaire
All daughters eligible for
vaccination whose parents
had agreed to participate in
research
Fisher’s exact
tests
553 daughters aged 12–13 years
(51%)
HPV Travel grants and
funding from GSK for
a vaccine clinical trial
Braun R. [35] 2013 To assess HPV vaccination practices,
use of the Vaccines for Children (VFC)
program, and knowledge about recent
legislation allowing for minor consent
to HPV vaccination (AB499)
Health care
organisations,
California, USA
Not
reported
Unclear (needs
assessment)
Not reported Not reported 44 Title X-funded health care
organizations
HPV Not reported
Brown E,
et al. [23]
2010 To explore GPs’ and practice nurses’
views of HPV vaccination, prior to
implementation of the national
immunisation programme
Three general
practices in
Hampshire and
Wiltshire, UK
Mar 2008 Semi-
structured
interviews
Convenience sample of
general practices;
recruitment of participants
unclear
Thematic
analysis &
principles of
constant
comparison
10 general practitioners & 7
practice nurses
HPV No conflicts of interest
Carolan K,
et al. [36]
2018 To investigate the impact of two
different education interventions on
attitudes towards vaccination in
young people
One secondary
school in north
west England,
UK
Jan 2016
and Jul
2016
Pre- and post-
intervention
questionnaires
(6-month
follow-up)
Recruitment took place in
one school: recruitment of
participants unclear
Kruskal-
Wallis & chi-
square test
63 young people aged 14–
15 years (94% White British)
Adolescent
vaccines
Not reported
Ford C, et al.
[24]
2009 To increase understanding of the
policy, legal, and financial issues
influencing efforts to achieve high
rates of adolescent vaccination
Nine states, five
jurisdictions,
and nationally,
USA
Not
reported
Semi-
structured
telephone
interviews
Purposive and snowballing Thematic
analysis
49 professionals with
responsibilities for adolescent
health care and/or vaccination
(58% response rate)
Adolescent
vaccines
Not reported
Ford C, et al.
[37,38]
2014 To explore whether, and to what
extent, minor consent influences
adolescent vaccine delivery in the
United States
National sample
of clinical
settings
Feb-Apr
2009
Cross-sectional
telephone
questionnaire
Purposive sample of
medical providers
Descriptive
analysis
263 medical providers (49.4%)
and public health professionals
from state or jurisdiction
immunization, STD, and family
planning programs (50.6%) (72%
response rate)
HPV, influenza
& Tdap
Co-investigators on
studies funded by
GlaxoSmithKline
Gottvall M,
et al. [25]
2015 To explore the relational aspects of the
consent process for HPV vaccination
as experienced by school nurses
Five towns/
districts,
Sweden
Apr-June
2010
Five focus
groups
Towns/districts selected
based on size & urbanicity;
All eligible participants
invited
Content
analysis
30 school nurses (43% response
rate)
HPV Not reported
Hilton S,
et al. [22]
2011 To investigate school nurses’
assessment of the HPV vaccine, their
experiences of delivering the school
based programme, and their views on
parental decision-making about HPV
vaccination
UK Sept
2008-
May 2009
Telephone
interviews
Purposive sample based on
experience, geographical
location & location of
schools
Constant
comparative
method
30 school nurses HPV No conflicts of interest
Humiston S,
et al. [29]
2009 To assess health care providers’
attitudes and practices regarding
adolescent immunizations, including
factors that either impede or facilitate
vaccination
Monroe County,
New York &
nationwide, USA
Spring
2005
Interviews &
focus groups
Purposive sample based on
location, practice type,
setting & patient
population
Grounded
theory
Focus groups: 21 primary care
practitioners (Monroe Country);
Interviews: 24 key informant
physicians & nurses (national)
Adolescent
vaccines
Speakers’ bureaus and
advisory boards for 3
companies that
manufacture vaccines
for adolescents
422
H
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al./V
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(2019)
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cation
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Geographical
Data
collection
period
Data collection
methods
Sampling strategy Analytical
method
Participants Vaccination
programme
Authors conflicts of
interest
Kennedy A,
et al. [39]
2012 To describe the vaccine-related
knowledge and attitudes of
adolescents aged 11–18 years and
parents of adolescents aged 11–
18 years
National,
population-
based, USA
2007 Cross-sectional
questionnaire
A stratified random sample
of 10,000 potential
respondents from a panel
of 600,000
Descriptive
analysis
1,087 adolescents aged 11–
18 years & 1,208 parents
HPV,
MenACWY,
&Tdap
Not reported
Kennedy C,
et al. [30]
2014 To explore vaccination views in
Scotland amongst parents, teenage
girls and health professionals across
three controversial vaccines
One health
board in
Scotland, UK
2008–
2010
Interviews &
focus groups
Purposive sample
(methodology unclear)
Thematic
analysis
51 healthcare professionals, 15
parents & 8 young women aged
12–15 years
HPV, influenza
A, a& MMR
No conflicts of interest
Lee H, et al.
[33]
2018 To identify potential barriers,
facilitators and decision-making
processes about HPV vaccinations
among Hmong adolescents
One local
community
health centre,
Minnesota, USA
Not
reported
Focus groups Not reported Participatory
thematic
analysis
13 Hmong parents & 12 Hmong
adolescents aged 14–17 years
HPV Not reported
Marshall H,
et al. [31]
2014 To seek adolescent and adult views on
how existing adolescent school-based
immunisation policy and program
delivery could be improved to
increase adolescent immunisation
uptake
Metropolitan
South Australia
2012 Citizen’s juries Stratified sampling to
ensure demographically
representative juries from
a standing panel
Thematic
analysis
15 adults & 16 adolescents aged
16–18 years
Adolescent
vaccines
No conflicts of interest
Pyrzanowski
J, et al.
[40]
2013 To describe younger and older
adolescents’ attitudes about health
care and vaccination in five settings
outside the traditional medical setting
Five schools in a
large, urban
public school
district, USA
Apr-May
2008
Cross-sectional
questionnaire
Purposive sample of
schools based on ethnicity
and socioeconomic
diversity; all eligible
students in participating
schools
Descriptive
analysis
392 adolescents aged 11–
12 years (73% response rate);
296 adolescents aged 16–
17 years (50% response rate)
Adolescent
vaccines
No conflicts of interest
Rand C, et al.
[41]
2011 To measure parent and adolescent
perceptions about new adolescent
vaccines
9 primary care
practices,
Monroe County,
New York, USA
Mar 2007
-Apr 2008
Telephone
cross-sectional
questionnaire
Convenience sample Chi-squared
test
430 parents & 208 adolescents
aged 15–17 years
Tdap, HPV,
influenza &
meningococcal
Not reported
Remes P,
et al. [28]
2012 To learn what people knew about
cervical cancer and HPV vaccination,
whether they would find HPV
vaccination acceptable, and how they
viewed vaccine delivery and consent
procedures
Two districts of
Mwanza city & a
neighbouring
rural district
(Misungwi),
Tanzania
Mar-Aug
2010
Semi
structured
interviews &
focus groups
Purposive Thematic
analysis
169 respondents (parents aged
18–59 years, religious leaders,
teachers, health workers, female
students aged 11–17 years)
HPV Travel grants &
funding from
GlaxoSmithKline,
Sanofi Pasteur MSD,
Merck & Co. or Qiage
Rylance G,
et al. [42]
1995 To determine children’s views on
consent issues
Two single sex
schools in
Birmingham, UK
Not
reported
Cross-sectional
questionnaire
Not reported Descriptive
analysis
513 students aged 11–15 years
(60% response rate)
Measles &
rubella
No conflicts of interest
Shah P, et al.
[43]
2014 To examine the preferences for
programmatic aspects of voluntary
school mass vaccination programs
Population-
based sample,
USA
Nov 2011 Cross-sectional
online survey
Participants from the HPV
Immunization in Sons (HIS)
longitudinal study
Paired t-tests 308 parents & 216 adolescent
sons aged 11–19 years (78%
follow-up)
Adolescent
vaccines
Funding from Merck
Sharp, Dohme Corp &
GlaxoSmithKline
Stretch R,
et al. [21]
2009 To assess school nurses views on
assessing Gillick competence and
vaccination of girls whose parents had
not given consent
Two PCTs in
Greater
Manchester, UK
Not
reported
Semi-
structured
interviews
All eligible school nurses
delivering HPV vaccination
programme
Thematic
analysis
15 of 32 school nurses (46.9%
response rate)
HPV Travel grants &
funding from GSK for
a vaccine clinical trial
Wilson S,
et al. [44]
2012 To evaluate the implementation of
Ontario’s publicly-funded, school-
based HPV immunization program
through a process evaluation
36 Public Health
Units, Ontario,
Canada
Feb-Apr
2010
Cross-sectional
questionnaire
Representatives at eligible
Public Health Units
Descriptive
analysis
41 vaccine-preventable disease
managers at 36 Public Health
Units
HPV No conflicts of interest
Wood F, et al.
[20]
2011 To explore the views of key
stakeholders about how the process of
consent should proceed where a
potential conflict exists between
parents
Wales, UK Not
reported
Semi-
structured
interviews
Convenience &
snowballing
Thematic
content
analysis
25 professionals involved in the
development of the HPV
vaccination programme
HPV No conflicts of interest
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(2019)
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Table 2
Risk of bias for primary studies incorporating qualitative research methodologies.
Study author Clear
statement of
the aims of the
research?
Qualitative
methodology
appropriate?
Research
design
justified?
Recruitment
strategy
appropriate?
Data
collection
methodology
appropriate?
Relationship
between researcher
and participants
considered?
Ethical issues
been taken
into
consideration?
Data
analysis
sufficiently
rigorous?
Clear
statement
of
findings?
How
valuable
is the
research?
Overall
risk of
bias
Batista Ferrer H,
et al. [26,27]
U U U U U U U U U U Low
Brabin L, et al. [32] U ✗ ✗ U ✗ ✗ U U U ✗ High
Brown E, et al. [23] U U ✗ ✗ U ✗ U U U U Moderate
Ford C, et al. [24] U U ✗ U ✗ ✗ U U U U Moderate
Gottvall M, et al.
[25]
U U ✗ U U U ✗ U U U Low
Hilton S, et al. [22] U U ✗ U U ✗ U U U U Low
Humiston S, et al.
[29]
U U ✗ U U ✗ ✗ U U ✗ Moderate
Kennedy C, et al.
[30]
U U ✗ U U ✗ U U U ✗ Moderate
Lee H, et al. [33] U U ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ High
Marshall H, et al.
[31]
U ✗ U ✗ U ✗ U ✗ U ✗ High
Remes P, et al. [28] U U ✗ U U ✗ ✗ ✗ U U Moderate
Stretch R, et al.
[21]
U U ✗ U U ✗ U U U U Low
Wood F, et al. [20] U U ✗ U U ✗ U U U U Low
424 H. Fisher et al. / Vaccine 37 (2019) 417–429implementation included concerns over school nurses’ compe-
tency [20] and practical aspects, such as time constraints and
space, related to the delivery of the vaccination programme
[20,21]: ‘‘If everybody is given 30 seconds to get in and out, you can’t
reasonably expect a nurse to make a decision in that time. Yes or no?
They would have to make some sort of later appointment to speak to
the young person and have a serious chat, which in itself then would
single them out from, you know if there was a mass queue” (Respon-
dent 17, Wales, [20]). School nurses indicated that they would rou-
tinely signpost young people who presented for vaccination
without written parental consent to a clinical setting [25,27]: ‘‘I
wouldn’t give them the shot myself, but I would give them a phone
number and the name of someone they could go to” (School nurse
3, Sweden, [25]).
Depending on the country, teachers could enable or constrain
implementation of adolescent self-consent procedures. In Tanza-
nia, some healthcare professionals were worried that teachers
could coerce young people into attending vaccination sessions held
at the school: ‘‘When we go to administer a vaccine, we find the
teachers have gathered the girls, and they are standing by the door
with a stick” (Health worker, Tanzania, [28]). Conversely, British
teachers were less supportive of adolescent self-consent and were
observed by a researcher in one study to physically prevent young
people without written parental consent from entering the vacci-
nation area [27]. No quantitative data was retrieved which related
to this issue.
3.9. Protection
The views and actions of healthcare professionals, parents and
young people in relation to adolescent self-consent for vaccination
were shaped by different issues of ‘protection’. Whilst vaccinations
may protect young people’s health, there were also concerns about
protecting the reputation of professionals and their relationships
with others, and the extent to which a young person’s confidential-
ity should be protected.
3.10. Young people’s health
Among participants there was acceptance that vaccines protect
young people’s health [20,21,28,32]. In some cases this related to
higher perceptions of the risk of disease acquisition, whichincreased acceptability of self-consent procedures for parents and
healthcare professionals [20,23,24,32]: ‘‘They should be able to
request it (HPV vaccine) – if they are having sex and seem able to
understand the issues” (Parent, England, [32]). Lower perceptions
of risk reduced acceptability [21]: ‘‘I know the younger they have
it the better, but there isn’t the same degree of urgency (for HPV)
and I would far rather sort it out and have everybody happy” (School
nurse 2, England, [21]). Conversely, self-consent procedures were
considered to pose a clinical risk to young people: some parents
and healthcare professionals believed that young people may not
provide accurate medical history information [21,32]: ‘‘There could
be a family history which may make it (the vaccine) unsuitable” (Par-
ent, England, [32]). No quantitative data was retrieved which
related to this issue.
3.11. Reputation of professionals
The study based in Tanzania suggested that healthcare profes-
sionals were supportive of young people providing self-consent
for vaccination, even when the parent had refused. This appeared
to result from a community-wide acceptance that healthcare pro-
fessionals act in the young person’s best interests: ‘‘What I aim at is
to save the life of the child, not the parent” (Healthcare professional,
Tanzania, [28]). In contrast, studies based in Sweden and the UK
suggest the reputation of healthcare professionals and teachers
could be jeopardised if parental preferences were not considered
[20,21,23,27,45]: ‘‘Because if you were to immunise a Gillick compe-
tent girl and her parents were dead against the vaccination, the ripples
that that would cause in the school, you know ‘the nurse immunised
my daughter even though we were against it’. It doesn’t really matter
what the law would say, you’ve undermined confidence in the service.
There are consequences” (Respondent 9, Wales, [20]). Similarly, only
a minority (39%) of representatives from Canadian healthcare
organisations indicated they would consider vaccinating compe-
tent students in the school-setting in the absence of parental con-
sent [44].
3.12. Relationships
Self-consent procedures could be enabled where the relation-
ship between healthcare professional and young person was priori-
tised: ‘‘Actually she’s being very responsible in coming and we want to
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H. Fisher et al. / Vaccine 37 (2019) 417–429 425encourage that. I still would feel extremely uneasy with going ahead
with the immunisation although you begin to feel then that you are
going against the fact that she is trying to do something very respon-
sible” (General practitioner, England, [23]). But more often, protect-
ing relationships with parents was given precedence over
implementation of self-consent procedures as healthcare profes-
sionals and teachers were fearful of repercussions [20,21,28].
Reaching consensus with the parent was preferred [20,21,23,25]:
‘‘Well, then we will have to do as we already do, and the parents will
have to be present. Participate, simply enough” (Nurse 4, Sweden,
[25]). Similarly, parents emphasised their role in providing con-
sent, suggesting that vaccination should not take place without
their involvement [20,30,32]: ‘‘I wouldn’t like my daughter to make
a lifechanging decision without being able to talk to me” (Parent, Eng-
land, [32]). Again, no quantitative data was retrieved which related
to this issue.
3.13. Confidentiality
Concern over the protection of young people’s confidentiality
varied. Following a vaccination request from a young person,
healthcare professionals may routinely inform parents without
regard for the young person’s right to privacy [20,21]: ‘‘I think you’d
probably need to make some contact with the parents, just to make
sure because I can understand that they would be perhaps rightfully
a little bit irritated that they had never been told. Yeah, although the
girl can consent on the day, I think the parents do need to be involved”
(Respondent 14, Wales, [20]). In the context of the UK HPV vacci-
nation programme, some parents and healthcare professionals
considered vaccination requests by young people could risk unin-
tentional disclosure of sexual activity [23,32]: ‘‘If you’ve got a
14 year old girl whose consent is it that they have it? The theory being
parental, but if they are sexually active and they haven’t told their par-
ents, and their parents are saying ‘Yes I consent to her having it’, and
she doesn’t want to say actually ‘There’s no point me having it because
I’m already sexually active’ then they might end up having it when
they might not want it or it might not be effective, and then they think
they’re covered and they’re not” (Practice nurse 16, England, [23]).
This quotation also highlights a lack of understanding that a young
person can still benefit from the vaccination if they are already sex-
ually active. Some parents felt they should be informed if sexual
behaviours were disclosed to healthcare professionals, with obvi-
ous implications for the confidentiality of young people [32]. No
quantitative data was retrieved which related to this issue.
3.14. Self-determination
The self-determination theme encompassed issues related to
parental responsibility, young people’s autonomy, and the charac-
teristics of young people.
3.15. Parental responsibility
Young people’s self-determination to consent could be under-
mined by perceptions that the responsibility to provide consent
for vaccinations belonged to the parent. In one study there was
recognition that the consent process in the UK HPV vaccination
programme favoured parents’ role in health-related decision-
making for their children: ‘‘I suppose the parents are going to over-
ride because they’ve got to actually sign the consent form” (General
practitioner 6, England, [23]).
Similarly, participants of qualitative studies felt strongly that
parents should remain responsible for providing consent for ado-
lescent vaccination [20,21,25,27,28,30–33]: ‘‘Certainly with my
younger daughter who was only 13 at the time. . .I would think well
I ought to have been consulted on that” (Mother, Scotland, [30]).
426 H. Fisher et al. / Vaccine 37 (2019) 417–429Other adults suggested that where there was disagreement, par-
ents’ vaccination preferences should be prioritised above that of
their son or daughter [20–22,27,28]: ‘‘If a child wants to have the
vaccination, they need to talk to someone about having it done
because their parents won’t let them have it and then interventions
can be put into place. There is no way you can be giving a vaccination
to a child without their parents’ consent. That is beyond crazy!”
(School teacher 3, England, [27]). This belief in parental consent
might also be shared by young people. A questionnaire study in
the USA showed that the majority of parents (70%) and their ado-
lescent children (72%) believed that adolescents should not be able
to self-consent for vaccination without parental knowledge and
consent ahead of vaccination [39].3.16. Young person’s autonomy
There was less evidence that participants supported young peo-
ple to be autonomous and self-consent for vaccinations. A minority
of British young people participating in an educational interven-
tion (30.1%) believed at baseline that adolescents should have
more say than their parents in relation to vaccination decisions
[36]. However, some healthcare professionals and parents sug-
gested that adolescents do have the right to make health-related
decisions [20,23,27,32,33]: ‘‘If they are old enough, regardless if
you say no as parents, they have the right to go” (Hmong Parent,
USA, [33]). Participants in another study maintained that young
people should be able to exercise autonomy and override parental
refusal for vaccination: ‘‘I should be vaccinated because I’m the one
who’ll contract the disease” (Student, Tanzania, [28]).
In a questionnaire study with British parents, 145 (48%)
strongly agreed or agreed that young people should be able to con-
sent for the HPV vaccine in a sexual health clinic without parental
consent [32]. A small proportion (7%) of British young people
offered the measles and rubella vaccine indicated they had been
asked to consent to receive the vaccine. The majority did not
believe that attending the immunisation session and cooperating
with the vaccination process implied consent (65%) and believed
that health professionals should not assume cooperation with the
vaccination process implies consent (58%) [42].3.17. Young person’s characteristics
Evidence from qualitative studies suggested that acceptability
of self-consent procedures can be influenced by the perceived
characteristics of the young person. The individual’s maturity and
competency, as opposed to age, appeared to be the predominant
factor for some parents and healthcare professionals [20,21,23–
25,32,33]: ‘‘You get some very mature but some look very tiny”
(School nurse 12, England, [21]). Young people were assumed as
not capable of making the ‘right’ vaccination-related decision or
avoiding vaccination due to fear of needles [30–32]: ‘‘Children. . .
will be informed but often times children are not the best judge to
be able to weigh their decisions without parents” (Parent, England,
[32]).
The perceived acceptable age to self-consent varied by country.
In the context of the Swedish and British HPV vaccination pro-
grammes, qualitative data highlighted that professionals and par-
ents were reticent to implement self-consent procedures due to
concerns that the target age for vaccination was too young (12–
13 years old) [20,21,25,32]. Healthcare professionals may be more
willing to support self-consent procedures with older adolescents
aged 15–16 years [21,25]: ‘‘If they are in high school and are 16 years
old, then I think they should be able to decide, even if the parents say
no. And then I would probably help them to get vaccinated without the
parents’ consent” (Nurse 3, Sweden, [25]).In contrast, evidence from two questionnaire studies demon-
strated that the majority (both 70%) of British young women aged
12–13 years believed they should be able to consent for vaccina-
tion without their parents’ consent [27,34], with unvaccinated
young women being less likely to agree [34]. In another study with
young people, on average being aged 12.3 years was considered
sufficient to demonstrate enough maturity and understanding to
consent for vaccination [42]. More recently, around one-third
(23/63) of young people aged 14–15 years agreed that well
informed young people under the age of 16 should be able to
receive vaccination without parental consent [36].
The perceived acceptable age for self-consent appeared to be
older in the USA. In one study, 69% of parents and 40% of their ado-
lescent sons believed that 18 years or older was an acceptable age
for adolescents to provide consent for vaccination [41]. Another
study showed that parents and sons believed on average 17 and
18 years, respectively, was an acceptable age for self-consent
[43]. Differences by age were also evident in the USA: at least
54% of healthcare professionals would be willing to vaccinate a
17-year-old adolescent without parental consent, whereas only
34% would vaccinate a 12-year-old [37,38]. Adolescents aged 16
to 17 years were reported to be more likely to agree that vaccina-
tion should take place without explicit parental consent than 11–
12 years olds (74% vs. 30%, respectively) [40].4. Discussion
4.1. Key findings
This synthesis of barriers and enablers to the implementation of
adolescent self-consent illustrates that local policies, professionals’
misunderstandings of the legal framework and the context in
which the vaccination programme was delivered could prevent
self-consent. Protection of young people’s health could act as an
enabler to adolescent self-consent. However, preserving the repu-
tation of professionals and existing relationships with parents
acted as a major barrier and young people’s right to confidentiality
was not always considered. Maintaining the role of parents as con-
senters for adolescent vaccinations was prioritised over enabling
young people to be autonomous in decisions affecting their health.
The target age for adolescent vaccination and perceptions of imma-
turity reduced the acceptability of adolescent self-consent proce-
dures to adults and some young people. A summary of the key
issues and implications for practice is summarised in Fig. 3.4.2. Comparison to the wider literature
Allowing competent young people to self-consent has the
potential to increase uptake of adolescent vaccination pro-
grammes. A recent systematic review showed complex, locally
designed interventions (including social media campaigns,
practice-based interventions, and reminders to parents) were most
effective at increasing vaccine uptake and reducing inequalities
[46]. As with the current systematic review, no intervention stud-
ies were captured that examined whether adolescent self-consent
procedures could increase uptake, although one study is underway
[47].
The methods for which legal frameworks for healthcare are
developed can lead to uncertainty as to how the law should be
practised in a clinical setting. Laws are evolved by judges in
response to cases that appear in the court setting, and do not act
as a comprehensive reference for healthcare professionals to follow
[48]. Further, the function of adolescent consent can vary according
to its application: transferring responsibility for decision-making is
considered the objective of gaining legal consent, while the
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Policy frameworks vary, and some do not support adolescent self-
consent.
Local interpretations may constrain self-consent.
Variations in policy lead to uncertainty amongst health professionals, 
parents, young people and other key stakeholders.
Greater consistency in policy 
frameworks is required.
Improved information, training and 
guidance is needed for key policy 
makers and health professionals.
CONTEXT: Country and
setting in which vaccination 
is administered
Some evidence of a preference for adolescent self-consent in clinical 
settings (but many adolescent vaccinations are schools-based).
Time and space constraints for school-based vaccination sessions 
restrict ability to assess competence to self-consent.
Perceptions of the appropriate age for self-consent varies by country.
Greater clarity and consistency is 
needed to facilitate adolescent self-
consent procedures across a variety 
of contexts.
Support may be required for 
assessment of competency in large-
scale vaccination settings (e.g. 
schools). 
ACTORS: Health 
professionals and other 
stakeholders involved in 
administering vaccinations
Opinions vary about whether adolescent self-consent is an appropriate 
policy for protecting young people’s health.
Health professionals vary in status and confidence about administering 
adolescent self-consent.
Health professionals’ concerns to protect their reputation and their 
relationships with parents and other adult stakeholders may take 
priority over adolescents’ rights to self-consent and confidentiality.
Improved information, training and 
guidance is required in relation to 
assessing adolescent competence to 
self-consent for vaccination.
The primacy of parental consent 
needs to be challenged if 
adolescents are to be enabled to 
make decisions about their 
healthcare.
Improved education and support 
should be provided to adolescents to 
enable them to make informed 
decisions about their healthcare.
ACTORS: Parents/carers
Predominant belief amongst health professionals, parents and young 
people that parents are responsible for their children’s health.
Parents expect to be informed about their children’s health / sexual 
activity. 
ACTORS: Young people
Adults perceptions of young people’s maturity influence the 
acceptability of self-consent.
Adolescent self-consent may be supported where priority is given to 
health professional’s relationship with young person. 
Drawing on the policy analysis triangle [47] which suggests that actors have a central role but are influenced by context, content and process.
Fig. 3. Summary of key issues from evidence synthesis and implications for practice.
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fostering cooperation, enabling decision-making, preventing harm
and doing good [48]. Further clarity is required at policy-level to
ensure that the national legal framework in relation to adolescent
consent is both applicable to, and practised within, local clinical
frameworks.
A recent ethical discourse explored the issue of adolescent self-
consent for HPV vaccination in the USA [49]. The authors con-
cluded clinicians are ethically justified in vaccinating young people
who make the request without parental consent. The authors
argued self-consent enables the advancement of important public
health goals with a negligible risk of harm through side-effects to
the young person. Further, respecting young people’s right to make
healthcare decisions could allow adolescents to develop autonomy
and become responsible adults [49]. We consider these arguments
should not be limited to vaccinations offering protection against
sexually transmitted infections, as they are equally applicable to
other adolescent vaccination programmes, and adolescent health-
care more generally.4.3. Strengths and limitations
A systematic search of multiple databases was undertaken to
identify all the relevant qualitative and quantitative literature
meeting the predetermined study criteria. Studies were not
excluded based on qualitative or quantitative research method,
publication date, publication language, or population group. This
has resulted in a comprehensive review capturing a range of per-
spectives in relation to barriers and enablers of self-consent for
adolescent vaccination programmes. We used an integrative
approach to synthesise qualitative and quantitative data [19]
which allowed the possibility of reaching conclusions based on
common elements identified across a range of studies. For exam-
ple, few primary studies specifically addressed the protection ofprofessionals’ reputation. However, when the studies were com-
bined more data on this topic was revealed.
As the majority of the studies focused on the HPV vaccine,
which protects against a sexually transmitted infection, it may be
expected that issues related to self-consent may differ for other
adolescent vaccinations. However, only three of the studies linked
adolescent self-consent with the sexual transmission of HPV
[23,25,32]. This suggests that the findings from this study are likely
to be applicable to other adolescent vaccination programmes.
There are some limitations. First, and most critically, there were
no intervention studies evaluating the impact of self-consent pro-
cedures on the uptake of adolescent vaccination programmes to
synthesise, which had been the primary aim of our study. While
only three of the qualitative studies included were at high risk of
bias [31–33], all the eligible quantitative studies were considered
at high risk. This was primarily due the choice of cross-sectional
study design comprising subjective, questionnaire data. Therefore,
the quantitative findings of this systematic review should be inter-
preted cautiously. It has not been possible to ascertain the preva-
lence of views related to some of the issues raised, such as
confidentiality and relationships, as no quantitative literature
was retrieved.
The findings from the primary studies did not explicitly con-
sider the potential impact of self-consent procedures amongst dif-
ferent population groups, such as young people from
socioeconomically disadvantaged backgrounds, minority ethnic
groups, or who are considered more vulnerable such as those with
an intellectual disability or looked after by the state and are
already known to experience adverse outcomes across multiple
health and social domains. Future studies should, where appropri-
ate, incorporate experimental study designs, objectively measured
outcomes, and be adequately powered to examine differences by
different population groups.
Although no exclusion criteria based on study setting was
applied, almost all studies meeting the inclusion criteria were from
428 H. Fisher et al. / Vaccine 37 (2019) 417–429high-income countries. Therefore, the results from the study limits
applicability of the findings within these settings. Further research
to understand barriers and enablers to adolescent self-consent in
low- and middle-income countries is suggested.
5. Conclusion
Our study findings show that implementation of adolescent
self-consent procedures is governed by the policy context in which
the vaccination programme is delivered and may be impeded by a
desire to protect the reputation of professionals and the role of par-
ents in decision-making. A key message from this synthesis is the
need to clarify the policy framework in relation to adolescent vac-
cination programmes and challenge the primacy of parental con-
sent. Supporting young people’s right to self-consent could help
develop autonomy and encourage responsible decision-making in
other health-related areas.
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